Dataset from iNNOVATE Study: A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Ibrutinib or Placebo in Combination With Rituximab in Subjects With Waldenström's Macroglobulinemia

NIAID Data Ecosystem2026-05-02 收录

华氏巨球蛋白血症临床试验

ibrutinib联合治疗

数据链接：

https://doi.org/10.25934/PR00007754 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the safety and efficacy of ibrutinib in combination with rituximab in participants with Waldenström's macroglobulinemia (WM).

创建时间：

2024-11-26

Dataset from iNNOVATE Study: A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Ibrutinib or Placebo in Combination With Rituximab in Subjects With Waldenström's Macroglobulinemia

资源简介：

相关数据集